Brez internetne povezave — prikazana je shranjena različica strani.

Cellectis SA

USUSD
← Na filter delnic

Cellectis SA (LSE:0WA2) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O podjetju

Spletna stran
cellectis.com
Odnosi z vlagatelji
cellectis.com/en/investors/governance/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
France, France
Izvršni direktor
Andre Choulika
Zaposleni
224
Ustanovljena
1999
Na borzi od
09.01.2018 (LSE:0WA2)
Delnice v obtoku
72.72 mio.
Prosto prenosljive delnice
48.58 mio.
Tržna kapitalizacija
148.06 mio. USD
Notranje osebe
0%
Institucionalni vlagatelji
15.36%
Panoga (SIC)
Biological Products, (No Diagnostic Substances)
Pravna oblika
QVPB
ISIN
FR0010425595
LEI
5493000KKX5VQ37Q2W83
FCF
−41.8 mio. USD
Dolg
0
Dobiček in FCF — za 12 mesecev do 31.12.2025 (najnovejše poročilo podjetja).
Opis

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.

Borze in oznake

BorzaOznakaValutaCenaVrsta
US USA StocksCMVLF OTCUSD3.47 +12.66%navadne delnice
LSE London Stock Exchange0WA2 IOBEUR2.65 +0.00%navadne delnice
PA Euronext ParisALCLS glavnaEUR1.128 +0.18%navadne delnice

Cena v 3 mesecih

dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Novice ta teden

Novic s spletnega mesta podjetja še ni.

oglas

Največji imetniki

ImetnikDeležDelniceDatum poročila
B Group, Inc.4.55%3.28 mio.2026-06-30
Long Focus Capital Manag…3.8%2.74 mio.2026-06-30
UBS AM, a distinct busin…3.67%2.64 mio.2026-06-30
iShares Trust-iShares Bi…0.33%235 6962026-08-31
Nomura Asset Management…0.31%226 8752026-06-30
Delaware Group Equity Fu…0.31%226 8752026-06-30
Blackrock Inc.0.31%225 4442026-06-30
Morgan Stanley0.12%85 4552026-06-30
LPL Financial LLC0.12%84 4152026-06-30
Susquehanna Internationa…0.07%50 4532026-06-30
BNP Paribas Financial Ma…0.06%40 1002026-06-30
UBS Group AG0.05%33 9262026-06-30
Fidelity Concord Street…0%1 9492026-07-31